+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Organ Transplantation Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 190 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4985888
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The organ transplantation market continues to evolve rapidly, shaped by clinical advancements, healthcare infrastructure improvements, and the strategic goals of health organizations. Senior leaders require up-to-date intelligence to seize opportunities, manage risks, and drive organizational success in transplantation services.

Organ Transplantation Market Snapshot

The global organ transplantation market is growing steadily, reaching a size of USD 19.91 billion in 2025 before increasing to USD 21.91 billion in 2026. Projections indicate further expansion to USD 40.50 billion by 2032, driven by a CAGR of 10.67%. Key growth factors include technological advancements in surgical processes, increased demand for transplants, and adoption of next-generation preservation and monitoring tools. The market’s progress also reflects wider patient eligibility, improved care coordination, and expanding infrastructure across regions, which set the stage for continued acceleration.

Scope & Segmentation of the Organ Transplantation Market

This report provides senior decision-makers with a thorough analysis of the organ transplantation market, organized by pivotal segments relevant for operational and strategic decision-making. The scope covers:

  • Organ Types: Examination of heart, kidney, liver, lung, and pancreas transplants, accounting for the distinct logistical, clinical, and therapeutic management requirements tied to each type.
  • Product Categories: Analysis includes immunosuppressive drugs, organ perfusion systems, preservation solutions, surgical instruments, accessories, and diagnostics or monitoring equipment, each pivotal for outcome optimization and workflow improvement.
  • Donor Sources: Differentiates between deceased and living donor procedures, providing insight into unique allocation processes, ethical considerations, and organizational responsibilities.
  • Care Settings: Identifies specific needs for ambulatory surgical centers, hospitals, and specialist transplantation centers, with relevance for technology rollouts and resource management.
  • Regional Markets: Focuses on market activities and adaptation strategies within the Americas, EMEA (Europe, Middle East, and Africa), and Asia-Pacific regions, demonstrating variation in regulatory landscape, policy frameworks, and investment priorities.

Additionally, the report explores how new medical technologies and regulatory shifts are influencing each segment, equipping stakeholders to prioritize entry strategies, guide product development, and allocate investments effectively within the organ transplantation market.

Organ Transplantation Market: Key Takeaways

  • Innovative preservation and perfusion technologies, as well as next-generation immunosuppression, are increasing transplant access and improving patient care.
  • Healthcare delivery models are shifting toward integrated approaches, emphasizing robust data systems, streamlined workflows, and enhanced post-transplant monitoring solutions.
  • Diversity in regional infrastructure, reimbursement pathways, and regulatory policies presents both challenges and opportunities for scaling technology adoption and ensuring effective operations across geographies.
  • Rising use of digital health and telemonitoring enables earlier detection of complications, reducing travel requirements for patients and allowing more targeted immunosuppressive therapy management.
  • Comprehensive service offerings—integrating product provision, clinical team education, and ongoing maintenance—support consistency of outcomes for large-scale provider networks.
  • Market strategies are evolving through collaboration among manufacturers, diagnostic leaders, and delivery organizations, supporting evidence-based decision-making and deployment of innovative solutions.

Tariff Impact: Navigating Procurement and Supply Risk

Shifts in United States tariffs have prompted a reassessment of procurement models throughout the organ transplantation sector. Increased import duties on medical devices and preservation materials are prompting organizations to examine supply chain resilience and cost management strategies:

  • Evaluate and adapt sourcing frameworks, leveraging local and diversified suppliers to mitigate disruptions and sustain continuity in transplant procedures.
  • Negotiate updated commercial terms, such as bundled offers or shared-risk agreements, aiming to control spending while ensuring essential supplies reach clinical settings seamlessly.
  • Promote closer collaboration among clinical, procurement, and finance teams to support cost containment and maintain access to vital transplantation technology.

Market Methodology & Data Sources

This research combines structured interviews with clinicians and procurement professionals, comprehensive literature review, and commercial insights from manufacturing and distribution partners. Consultation with subject-matter experts and application of data triangulation bolster the accuracy and relevance of findings for the organ transplantation market.

Why This Organ Transplantation Market Report Matters

  • Enables robust strategic planning by detailing the interconnected medical, regulatory, and commercial elements in transplantation.
  • Supports evidence-based choices for new products, partnerships, or resource allocations, tailored to regional and organizational contexts.
  • Delivers actionable insights into operational and procurement hurdles, assisting organizations to proactively manage evolving market challenges.

Conclusion

Realizing the strategic potential of the organ transplantation market requires organizations to align clinical aspirations with operational delivery, ensuring sustained advancement and improved outcomes across patient populations and systems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Organ Transplantation Market, by Type of Organ
8.1. Heart Transplantation
8.2. Kidney Transplantation
8.3. Liver Transplantation
8.4. Lung Transplantation
8.5. Pancreas Transplantation
9. Organ Transplantation Market, by Product Type
9.1. Immunosuppressive Drugs
9.2. Organ Perfusion Systems
9.3. Preservation Solutions
9.4. Surgical Instruments & Accessories
9.5. Transplant Diagnostics & Monitoring
10. Organ Transplantation Market, by Source of Organs
10.1. Deceased
10.2. Living
11. Organ Transplantation Market, by End-User
11.1. Ambulatory Surgical Centers
11.2. Hospitals
11.3. Transplantation Centers
12. Organ Transplantation Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Organ Transplantation Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Organ Transplantation Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Organ Transplantation Market
16. China Organ Transplantation Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. 21st Century Medicine
17.6. Abbott Laboratories
17.7. AbbVie Inc.
17.8. Astellas Pharma Inc.
17.9. Bio-Rad Laboratories, Inc.
17.10. BiolifeSolutions, Inc.
17.11. Bridge to Life Ltd.
17.12. Bristol-Myers Squibb Company
17.13. CHIESI Farmaceutici S.p.A.
17.14. Dr. Franz Kohler Chemie GmbH
17.15. eGenesis Inc.
17.16. F. Hoffmann-La Roche Ltd
17.17. Illumina, Inc.
17.18. Medtronic PLC
17.19. Novartis AG
17.20. Organ Recovery Systems, Inc.
17.21. Organovo, Inc.
17.22. OrganOx Limited
17.23. Pfizer Inc.
17.24. Plexision, Inc.
17.25. Preservation Solutions, Inc.
17.26. Sanofi S.A.
17.27. Stryker Corporation
17.28. Terumo Corporation
17.29. Teva Pharmaceuticals Industries Ltd.
17.30. Thermo Fisher Scientific Inc.
17.31. TransMedics Group, Inc.
17.32. United Therapeutics Corporation
17.33. Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
17.34. Vivalyx GmbH
17.35. Xvivo Perfusion AB
List of Figures
FIGURE 1. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA ORGAN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY ORGAN PERFUSION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY ORGAN PERFUSION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY ORGAN PERFUSION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRESERVATION SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRESERVATION SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PRESERVATION SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SURGICAL INSTRUMENTS & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SURGICAL INSTRUMENTS & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SURGICAL INSTRUMENTS & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT DIAGNOSTICS & MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT DIAGNOSTICS & MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT DIAGNOSTICS & MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY DECEASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY DECEASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY DECEASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVING, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANTATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 53. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 54. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 55. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 56. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 57. NORTH AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. NORTH AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 59. NORTH AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 60. NORTH AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 61. NORTH AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 62. LATIN AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. LATIN AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 64. LATIN AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 65. LATIN AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 66. LATIN AMERICA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 67. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 72. EUROPE ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. EUROPE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 74. EUROPE ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 75. EUROPE ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 76. EUROPE ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 77. MIDDLE EAST ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. MIDDLE EAST ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 79. MIDDLE EAST ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 80. MIDDLE EAST ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 81. MIDDLE EAST ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 82. AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 84. AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 86. AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 91. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. ASEAN ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. ASEAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 95. ASEAN ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 96. ASEAN ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 97. ASEAN ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 98. GCC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GCC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 100. GCC ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 101. GCC ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 102. GCC ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPEAN UNION ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. EUROPEAN UNION ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 105. EUROPEAN UNION ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. EUROPEAN UNION ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 107. EUROPEAN UNION ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 108. BRICS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. BRICS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 110. BRICS ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 111. BRICS ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 112. BRICS ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 113. G7 ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. G7 ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 115. G7 ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 116. G7 ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 117. G7 ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 118. NATO ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. NATO ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 120. NATO ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 121. NATO ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 122. NATO ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 125. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 126. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 128. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 129. CHINA ORGAN TRANSPLANTATION MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 130. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE OF ORGAN, 2018-2032 (USD MILLION)
TABLE 131. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY SOURCE OF ORGANS, 2018-2032 (USD MILLION)
TABLE 133. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Organ Transplantation market report include:
  • 21st Century Medicine
  • Abbott Laboratories
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Bio-Rad Laboratories, Inc.
  • BiolifeSolutions, Inc.
  • Bridge to Life Ltd.
  • Bristol-Myers Squibb Company
  • CHIESI Farmaceutici S.p.A.
  • Dr. Franz Kohler Chemie GmbH
  • eGenesis Inc.
  • F. Hoffmann-La Roche Ltd
  • Illumina, Inc.
  • Medtronic PLC
  • Novartis AG
  • Organ Recovery Systems, Inc.
  • Organovo, Inc.
  • OrganOx Limited
  • Pfizer Inc.
  • Plexision, Inc.
  • Preservation Solutions, Inc.
  • Sanofi S.A.
  • Stryker Corporation
  • Terumo Corporation
  • Teva Pharmaceuticals Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • TransMedics Group, Inc.
  • United Therapeutics Corporation
  • Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
  • Vivalyx GmbH
  • Xvivo Perfusion AB

Table Information